Cook Joseph, Sapia Molly, Walker Chris, Pittaoulis Melissa
Viatris, Canonsburg, PA 15317, USA.
NERA Economic Consulting, New York, NY 10036, USA.
Healthcare (Basel). 2024 Sep 12;12(18):1827. doi: 10.3390/healthcare12181827.
Dysphagia is common, but there is limited information about its prevalence and patient preferences regarding dosage forms (oral solids, liquids, topical, etc.) in Brazil, China, the United Kingdom (UK), and Indonesia.
We conducted an online survey of 1000 adults from each country, without any required disease, to estimate the prevalence of dysphagia in these four nations and the dosage form preferences among UK patients.
A total of 36.9%, 40.5%, 54.9%, and 64.5% from the UK, Indonesia, Brazil, and China, respectively, had an Eating Assessment Tool (EAT-10) score of ≥3 (indicative of dysphagia). Only 2% of UK respondents and 5% of Brazilian respondents reported a formal diagnosis of dysphagia. Indonesian (74%) and Chinese respondents (77%) were more likely than Brazilian (52%) and UK respondents (45%) to report that their swallowing problems affected their ability to adhere to medication instructions. Liquids were the oral medication formulation most preferred by those who reported difficulty swallowing.
To conclude, substantial populations have difficulty swallowing, which can translate into an access issue for medical treatment. The availability of people's preferred dosage forms may help alleviate the adherence issues associated with difficulty swallowing and the concomitant effects on health outcomes.
吞咽困难很常见,但在巴西、中国、英国和印度尼西亚,关于其患病率以及患者对剂型(口服固体、液体、局部用药等)的偏好的信息有限。
我们对来自每个国家的1000名无任何特定疾病的成年人进行了在线调查,以估计这四个国家吞咽困难的患病率以及英国患者对剂型的偏好。
英国、印度尼西亚、巴西和中国分别有36.9%、40.5%、54.9%和64.5%的人饮食评估工具(EAT - 10)得分≥3(表明存在吞咽困难)。只有2%的英国受访者和5%的巴西受访者报告有吞咽困难的正式诊断。印度尼西亚(74%)和中国受访者(77%)比巴西(52%)和英国受访者(45%)更有可能报告他们的吞咽问题影响了他们遵守用药说明的能力。液体剂型是那些报告有吞咽困难的人最喜欢的口服药物剂型。
总之,相当一部分人群存在吞咽困难,这可能会转化为医疗治疗的可及性问题。提供人们喜欢的剂型可能有助于缓解与吞咽困难相关的依从性问题以及对健康结果的连带影响。